Botulinum toxin (Dysportt) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study

Hyman, N.; Barnes, M.; Bhakta, B.; Cozens, A.; Bakheit, M.; Kreczy-Kleedorfer, B.; Poewe, W.; Wissel, J.; Bain, P.; Glickman, S.; Sayer, A.; Richardson, A.; Dott, C.
June 2000
Journal of Neurology, Neurosurgery & Psychiatry;Jun2000, p707
Academic Journal
No abstract available.


Related Articles

  • Botulinum toxin treatment of adult spasticity : a benefit-risk assessment. Sheean, Geoffrey // Drug Safety;2006, Vol. 29 Issue 1, p31 

    Injections of botulinum toxin have revolutionised the treatment of focal spasticity. Before their advent, the medical treatment for focal spasticity involved oral antispasticity drugs, which had decidedly non-focal adverse effects, and phenol injections. Phenol injections could be difficult to...

  • Botulinum Toxin A (Dysport®): In Dystonias and Focal Spasticity. Keam, Susan J.; Muir, Victoria J.; Deeks, Emma D. // Drugs;2011, Vol. 71 Issue 8, p1043 

    Dysport®, a formulation of botulinum toxin A, blocks acetylcholine release at neuromuscular junctions causing denervation and temporary muscle paralysis. It is used to treat several medical conditions, including dystonias and focal spasticity. Subcutaneous Dysport® was effective in...

  • Placebo controlled, randomised, double blind study of the effects of botulinumA toxin on detrusor sphincter dyssynergia in multiple sclerosis patients. Gallien, P.; Reymann, J.-M.; Amarenco, G.; Nicolas, B.; de Sèze, M.; Bellissant, E. // Journal of Neurology, Neurosurgery & Psychiatry;Dec2005, Vol. 76 Issue 12, p1670 

    Objective: The purpose of the study was to evaluate the efficacy and safety of botulinum A toxin in the treatment of detrusor sphincter dyssynergia in multiple sclerosis patients. Methods: This was a multicentre, placebo controlled, randomised, double blind study. Patients with chronic urinary...

  • Shoulder pain and external rotation in spastic hemiplegia do not improve by injection of botulinum toxin A into the subscapular muscle. de Boer, K. S.; Arwert, H. J.; de Groat, J. H.; Meskers, C. G. M.; Mishre, A. D. Rambaran; Arendzen, J. H. // Journal of Neurology, Neurosurgery & Psychiatry;May2008, Vol. 79 Issue 5, p581 

    Objective: To study the effect of botulinum toxin A in the subscapular muscle on shoulder pain and humerus external rotation. Methods: 22 stroke patients with spastic hemiplegia, substantial shoulder pain and reduced external rotation of the humerus participated in a randomised, double blind,...

  • A small dose of poison helps the nutriments go down.  // Patient Care;11/15/1995, Vol. 29 Issue 18, p9 

    Presents the result of the study on the treatment of achalasia by botulinum toxin in a randomized, double-blind, placebo-controlled study. Benefits of botulin toxin to several patients; Alternative medicine for the treatment of achalasia.

  • Decreased flexion contracture after total knee arthroplasty using Botulinum toxin A: a randomized controlled trial. Smith, Eric; Shafi, Karim; Greis, Ari; Maltenfort, Mitchell; Chen, Antonia; Smith, Eric B; Shafi, Karim A; Greis, Ari C; Maltenfort, Mitchell G; Chen, Antonia F // Knee Surgery, Sports Traumatology, Arthroscopy;Oct2016, Vol. 24 Issue 10, p3229 

    Purpose: Flexion contracture after total knee arthroplasty (TKA) can cause significant dissatisfaction. Botulinum toxin A has shown improved extension in patients with spastic flexion contractures after TKA. The purpose of this study was to evaluate whether Botulinum toxin A...

  • The Myriad Uses of Botulinum Toxin. Pullman, Seth L. // Annals of Internal Medicine;12/6/2005, Vol. 143 Issue 11, p838 

    The article presents information about the uses of Botulinum Toxin (BTx). BTx is an important therapeutic agent with widespread applications in neurologic and non-neurologic disease. Double-blind, placebo-controlled clinical trials have shown that BTx safely and effectively resolves excessive...

  • Botulinum Toxin B: A Review of its Therapeutic Potential in the Management of Cervical Dystonia. Figgitt, D.P.; Noble, S. // Drugs;2002, Vol. 62 Issue 4, p705 

    Botulinum toxins are well known as the causative agents of human botulism food poisoning. However, in the past two decades they have become an important therapeutic mainstay in the treatment of dystonias including cervical dystonia, a neurological disorder characterised by involuntary...

  • Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. Yelnik, Alain P.; Colle, Florence M.; Bonan, Isabelle V.; Vicaut, Eric // Journal of Neurology, Neurosurgery & Psychiatry;Aug2007, Vol. 78 Issue 8, p845 

    Objective: This randomised, double blind, placebo controlled, two parallel group study was conducted to assess the beneficial effect of injection of botulinum toxin A (Dysport) into the subscapularis muscle on shoulder pain in stroke patients with spastic hemiplegia. Methods: A single dose of...

  • PO-RR-094-SA.  // Physical Therapy;May1997, Vol. 77 Issue 5, pS31 

    Presents an abstract of a paper entitled `Botulinum Toxin Type A in the Treatment of Upper Extremity Spasticity: A Randomized, Double-Blind, Placebo-Controlled Trail,' by D.M. Simpson, D.N. Alexander et al, presented at the Physical Therapy `97: Scientific Meeting and Exposition of the American...


Read the Article


Sign out of this library

Other Topics